XML 59 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investments in and Advances to Unconsolidated Joint Ventures (Tables)
9 Months Ended
Sep. 30, 2014
Investments in and Advances to Unconsolidated Joint Ventures  
Company owned interests in entities, accounted under equity method

 

 

 

 

 

 

 

 

 

 

 

Entity(1)

    

Segment

    

Investment(2)

    

Ownership%

 

CCRC JV(3) 

 

senior housing

 

$

459,916 

 

 

49

 

 

HCR ManorCare

 

post-acute/skilled nursing

 

 

76,876 

 

 

9.4

 

 

HCP Ventures III, LLC

 

medical office

 

 

6,868 

 

 

30

 

 

HCP Ventures IV, LLC

 

medical office and hospital

 

 

27,560 

 

 

20

 

 

HCP Life Science(4) 

 

life science

 

 

70,771 

 

50 

63

 

Suburban Properties, LLC

 

medical office

 

 

5,716 

 

 

67

 

 

Advances to unconsolidated joint ventures, net

 

 

 

 

216 

 

 

 

 

 

 

 

 

 

$

647,923 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Edgewood Assisted Living Center, LLC

 

senior housing

 

$

(440)

 

 

 

 

 

Seminole Shores Living Center, LLC

 

senior housing

 

 

(645)

 

 

 

 

 

 

 

 

 

$

(1,085)

 

 

 

 

 


(1)  These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.

(2)  Represents the carrying value of the Company’s investment in the unconsolidated joint ventures. Negative balances are recorded in accounts payable and accrued liabilities on the Company’s Condensed Consolidated Balance Sheets.

(3)  Includes two unconsolidated joint ventures between the Company and Brookdale: (i) CCRC PropCo ($210 million) and (ii) CCRC OpCo ($250 million). See additional information regarding the Brookdale Transaction in Note 3.

(4)  Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).

Summarized combined financial information for unconsolidated joint ventures

 

 

 

 

 

 

 

 

 

    

September 30,

 

December 31,

 

 

 

2014(1)

  

2013

 

Real estate, net

 

$

5,159,092 

 

$

3,662,450 

 

Goodwill and other assets, net

 

 

5,482,542 

 

 

5,384,553 

 

Total assets

 

$

10,641,634 

 

$

9,047,003 

 

 

 

 

 

 

 

 

 

Capital lease obligations and debt

 

$

7,221,580 

 

$

6,768,815 

 

Accounts payable

 

 

1,103,072 

 

 

1,045,260 

 

Other partners’ capital

 

 

1,648,992 

 

 

1,098,228 

 

HCP’s capital(2) 

 

 

667,990 

 

 

134,700 

 

Total liabilities and partners’ capital

 

$

10,641,634 

 

$

9,047,003 

 


(1)  Includes the financial information of the CCRC JV, which the Company formed on August 29, 2014.

(2)  The combined basis difference of the Company’s investments in these joint ventures of $21 million, as of September 30, 2014, is primarily attributable to goodwill, real estate, capital lease obligations, deferred tax assets and lease-related net intangibles.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

    

2014(1)

  

2013

  

2014(1)

  

2013

 

Total revenues

 

$

1,087,010 

 

$

1,046,789 

 

$

3,224,839 

 

$

3,182,052 

 

Income (loss) from discontinued operations

 

 

3,600 

 

 

(2,600)

 

 

(2,000)

 

 

(8,300)

 

Net income (loss)

 

 

(702)

 

 

2,538 

 

 

(4,826)

 

 

23,032 

 

HCP’s share of earnings(2) 

 

 

10,168 

 

 

13,892 

 

 

39,388 

 

 

44,278 

 

Fees earned by HCP

 

 

447 

 

 

464 

 

 

1,340 

 

 

1,406 

 

Distributions received by HCP

 

 

2,113 

 

 

1,390 

 

 

5,881 

 

 

3,918 

 


(1)  Includes the financial information of the CCRC JV, which the Company formed on August 29, 2014.

(2)  The Company’s joint venture interest in HCR ManorCare is accounted for using the equity method and results in an ongoing elimination of DFL income proportional to HCP’s ownership in HCR ManorCare. The elimination of the respective proportional lease expense at the HCR ManorCare level in substance results in $16 million and $15 million of DFL income that is recharacterized to the Company’s share of earnings from HCR ManorCare (equity income from unconsolidated joint ventures) for the three months ended September 30, 2014 and 2013, respectively. For both the nine months ended September 30, 2014 and 2013, $47 million of DFL income was recharacterized to the Company’s share of earnings from HCR ManorCare.